Loffredo John T, Bean Alex T, Beal Dominic R, León Enrique J, May Gemma E, Piaskowski Shari M, Furlott Jessica R, Reed Jason, Musani Solomon K, Rakasz Eva G, Friedrich Thomas C, Wilson Nancy A, Allison David B, Watkins David I
Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, 555 Science Dr., Madison, WI 53711, USA.
J Virol. 2008 Feb;82(4):1723-38. doi: 10.1128/JVI.02084-07. Epub 2007 Dec 5.
Certain major histocompatibility complex (MHC) class I alleles are strongly associated with control of human immunodeficiency virus and simian immunodeficiency virus (SIV). CD8(+) T cells specific for epitopes restricted by these molecules may be particularly effective. Understanding how CD8(+) T cells contribute to control of viral replication should yield important insights for vaccine design. We have recently identified an Indian rhesus macaque MHC class I allele, Mamu-B08, associated with elite control and low plasma viremia after infection with the pathogenic isolate SIVmac239. Here, we infected four Mamu-B08-positive macaques with SIVmac239 to investigate why some of these macaques control viral replication. Three of the four macaques controlled SIVmac239 replication with plasma virus concentrations below 20,000 viral RNA copies/ml at 20 weeks postinfection; two of four macaques were elite controllers (ECs). Interestingly, two of the four macaques preserved their CD4(+) memory T lymphocytes during peak viremia, and all four recovered their CD4(+) memory T lymphocytes in the chronic phase of infection. Mamu-B08-restricted CD8(+) T-cell responses dominated the acute phase and accounted for 23.3% to 59.6% of the total SIV-specific immune responses. Additionally, the ECs mounted strong and broad CD8(+) T-cell responses against several epitopes in Vif and Nef. Mamu-B08-specific CD8(+) T cells accounted for the majority of mutations in the virus at 18 weeks postinfection. Interestingly, patterns of viral variation in Nef differed between the ECs and the other two macaques. Natural containment of AIDS virus replication in Mamu-B*08-positive macaques may, therefore, be related to a combination of immunodominance and viral escape from CD8(+) T-cell responses.
某些主要组织相容性复合体(MHC)I类等位基因与人类免疫缺陷病毒和猿猴免疫缺陷病毒(SIV)的控制密切相关。受这些分子限制的表位特异性CD8(+) T细胞可能特别有效。了解CD8(+) T细胞如何有助于控制病毒复制,将为疫苗设计提供重要见解。我们最近鉴定出一种印度恒河猴MHC I类等位基因Mamu-B08,它与感染致病性毒株SIVmac239后的精英控制和低血浆病毒血症相关。在此,我们用SIVmac239感染了四只Mamu-B08阳性猕猴,以研究为什么其中一些猕猴能够控制病毒复制。四只猕猴中有三只在感染后20周时控制了SIVmac239的复制,血浆病毒浓度低于20,000病毒RNA拷贝/毫升;四只猕猴中有两只为精英控制者(ECs)。有趣的是,四只猕猴中有两只在病毒血症高峰期保留了其CD4(+)记忆性T淋巴细胞,并且在感染的慢性期全部四只猕猴都恢复了其CD4(+)记忆性T淋巴细胞。Mamu-B08限制的CD8(+) T细胞反应在急性期占主导地位,占SIV特异性免疫反应总数的23.3%至59.6%。此外,精英控制者针对Vif和Nef中的几个表位产生了强烈而广泛的CD8(+) T细胞反应。感染后18周时,Mamu-B08特异性CD8(+) T细胞占病毒中大多数突变。有趣的是,精英控制者和其他两只猕猴之间Nef中的病毒变异模式不同。因此,Mamu-B*08阳性猕猴中艾滋病病毒复制的自然控制可能与免疫优势和病毒逃避CD8(+) T细胞反应的组合有关。